(Q35847642)

10 August 2017

1 reference

title

Management of recurrent disease after radical prostatectomy (English)

1 reference

10 August 2017

Bott SR

1

1 reference

10 August 2017

publication date

1 January 2004

1 reference

Prostate Cancer and Prostatic Diseases

10 August 2017

published in

1 reference

10 August 2017

volume

7

1 reference

10 August 2017

issue

3

1 reference

10 August 2017

page(s)

211-216

1 reference

Natural history of progression after PSA elevation following radical prostatectomy

10 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500732

Patient-re ported complications and follow-up treatment after radical prostatectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500732

Undetectable ultrasensitive PSA after radical prostatectomy for prostate cancer predicts relapse-free survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500732

Prostate specific antigen in the preoperative and postoperative evaluation of localized prostatic cancer treated with radical prostatectomy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500732

Is there a role for digital rectal examination in the followup of patients after radical prostatectomy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500732

Yield of imaging and scintigraphy assessing biochemical failure in prostate cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500732

Advances in imaging in the postoperative patient with a rising prostate-specific antigen level

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500732

Noninvasive detection of clinically occult lymph-node metastases in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500732

Local recurrence after radical prostatectomy: characteristics in size, location, and relationship to prostate-specific antigen and surgical margins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500732

Factors predicting cancer detection in biopsy of the prostatic fossa after radical prostatectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500732

Multiple vesico-urethral biopsies following radical prostatectomy: the predictive roles of TRUS, DRE, PSA and the pathological stage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500732

Long-term biochemical disease-free and cancer-specific survival following anatomic radical retropubic prostatectomy. The 15-year Johns Hopkins experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500732

Biochemical (prostate specific antigen) recurrence probability following radical prostatectomy for clinically localized prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500732

Radiotherapy after radical prostatectomy: treatment outcomes and failure patterns

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500732

Recurrence patterns after radical retropubic prostatectomy: clinical usefulness of prostate specific antigen doubling times and log slope prostate specific antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500732

Evaluation of serum prostate-specific antigen velocity after radical prostatectomy to distinguish local recurrence from distant metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500732

Use of nomograms to predict the risk of disease recurrence after definitive local therapy for prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500732

Selection of men at high risk for disease recurrence for experimental adjuvant therapy following radical prostatectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500732

Salvage brachytherapy for local recurrence after radical prostatectomy and subsequent external beam radiotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500732

Evaluation and management of men whose radical prostatectomies failed: results of an international survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500732

Long-term results of three-dimensional conformal adjuvant and salvage radiotherapy after radical prostatectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500732

Predictors of biochemical outcome with salvage conformal radiotherapy after radical prostatectomy for prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500732

Consensus statements on radiation therapy of prostate cancer: guidelines for prostate re-biopsy after radiation and for radiation therapy with rising prostate-specific antigen levels after radical prostatectomy. American Society for Therapeutic Radi

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500732

Irradiation for locally recurrent carcinoma of the prostate following radical prostatectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500732

Impact of postprostatectomy prostate-specific antigen nadir on outcomes following salvage radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500732

Salvage radiotherapy in the treatment of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500732

Maximum androgen-blockade with medical or surgical castration in advanced prostate cancer: A meta-analysis of nine published randomized controlled trials and 4128 patients using flutamide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500732

Bicalutamide as Immediate Therapy Either Alone or as Adjuvant to Standard Care of Patients with Localized or Locally Advanced Prostate Cancer: First Analysis of the Early Prostate Cancer Program

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500732

Prospective randomized trial comparing flutamide as adjuvant treatment versus observation after radical prostatectomy for locally advanced, lymph node-negative prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500732

The role of antiandrogen monotherapy in the treatment of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500732

Antiandrogen monotherapy: a new form of treatment for patients with prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500732

Follow-up prostate cancer treatments after radical prostatectomy: a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500732

7 January 2021

Correlation of pathologic findings with progression after radical retropubic prostatectomy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500732

7 January 2021

The value of serum prostate specific antigen determinations before and after radical prostatectomy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500732

7 January 2021

Prostate-specific antigen after anatomic radical retropubic prostatectomy. Patterns of recurrence and cancer control

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500732

7 January 2021

Vesicourethral anastomosis biopsy after radical prostatectomy: predictive value of prostate-specific antigen and pathologic stage

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500732

7 January 2021

Correlation of clinical and pathologic factors with rising prostate-specific antigen profiles after radical prostatectomy alone for clinically localized prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500732

7 January 2021

The Incidence and Significance of Detectable Levels of Serum Prostate Specific Antigen After Radical Prostatectomy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500732

7 January 2021

Limited suppression of prostate-specific antigen after salvage radiotherapy for its isolated elevation after radical prostatectomy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500732

7 January 2021

Long-term results of radiation therapy for prostate cancer recurrence following radical prostatectomy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500732

7 January 2021

Prognostic significance of lymph nodal metastases in prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500732

7 January 2021

Salvage radiotherapy for biochemical recurrence after radical prostatectomy: a study of 62 patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500732

7 January 2021

Postoperative prostate-specific antigen as a prognostic indicator in patients with margin-positive prostate cancer, undergoing adjuvant radiotherapy after radical prostatectomy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500732

7 January 2021

Radiotherapy for isolated increases in serum prostate-specific antigen levels after radical prostatectomy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500732

7 January 2021

Radiotherapy for a rising prostate-specific antigen after radical prostatectomy: the first 10 years

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500732

7 January 2021

The efficacy of early adjuvant radiation therapy for pT3N0 prostate cancer: a matched-pair analysis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500732

7 January 2021

Immediate versus deferred treatment for advanced prostatic cancer: initial results of the Medical Research Council trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500732

7 January 2021

Immediate hormonal therapy compared with observation after radical prostatectomy and pelvic lymphadenectomy in men with node-positive prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500732

7 January 2021

Identifiers

DOI

10.1038/SJ.PCAN.4500732

1 reference

Dimensions Publication ID

10 August 2017

1019906677

0 references

1 reference